Will Scrimshaw
About Will Scrimshaw
Will Scrimshaw is the General Counsel & Company Secretary at BenevolentAI in London, with over 20 years of experience in the technology sector and a background in law.
Company
Will Scrimshaw is currently serving as the General Counsel & Company Secretary at BenevolentAI. Based in London, United Kingdom, he works in a hybrid capacity. BenevolentAI is known for its focus on artificial intelligence and drug discovery. Will oversees the company's legal affairs and corporate governance.
Title
As the General Counsel & Company Secretary at BenevolentAI, Will Scrimshaw is responsible for managing legal affairs and ensuring corporate governance. His role encompasses providing strategic legal advice, product counselling, and business development support.
Education and Expertise
Will Scrimshaw studied law at the University of Bristol, achieving a Bachelor of Laws - LLB, and later completed the LPC at the Oxford Institute of Legal Practice. He has over 20 years of experience in the technology sector, offering expertise in corporate fundraising, employment law, AI and privacy governance, and intellectual property management. Additionally, his background includes handling commercial litigation across various jurisdictions and industries.
Career History
Will Scrimshaw has an extensive career history, including roles at prominent companies in the legal and technology sectors. He served as Director, EU Government Affairs, and Head of Legal, Senior Attorney at Microsoft between 2012 and 2019. Prior to Microsoft, he was Senior Counsel at Skype and a Solicitor in Commercial Litigation at BT plc. He began his career at Norton Rose (Fulbright), working as both a Trainee Solicitor and later as an Associate in Intellectual Property and Technology.
Achievements
Will Scrimshaw has been recognized for his contributions to the legal and technology fields. He received the Microsoft Pro Bono Volunteer of the Year award for his work with Kids in Need of Defense UK. At BenevolentAI, he played a key role in the company's public listing through a deSPAC business combination in April 2022. He is involved in overseeing ESG initiatives and ensuring compliance with data protection and privacy regulations. Additionally, he contributes to strategic collaborations, such as those with Merck and AstraZeneca.